Jove
Visualize
Contact Us

Related Concept Videos

Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

231
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
231
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

217
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
217
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

322
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
322
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

177
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
177
Other Pulmonary Disorders01:17

Other Pulmonary Disorders

827
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
827
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

134
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
134

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Tobacco in films and smoking among young people].

La Revue du praticien·2026
Same author

[Strengthening therapeutic education for tuberculosis patients].

Revue de l'infirmiere·2025
Same author

[Support for seniors who want to quit smoking].

Revue de l'infirmiere·2025
Same author

[Drug interactions: the effects of smoking].

La Revue du praticien·2025
Same author

Vascular diseases (Paris, France)·2025
Same author

[Nurses: key players in helping people to stop smoking].

Revue de l'infirmiere·2025
Same journal

[Prolonged fever].

La Revue du praticien·2026
Same journal

[Lower gastrointestinal bleeding].

La Revue du praticien·2026
Same journal

[Management of antiplatelet agents and oral anticoagulants in cases of gastrointestinal bleeding].

La Revue du praticien·2026
Same journal

[A history of child abuse intervention in the West].

La Revue du praticien·2026
Same journal

[Agranulocytose médicamenteuse].

La Revue du praticien·2026
Same journal

[Patient education in heart failure].

La Revue du praticien·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 24, 2025

Methods to Evaluate Cytotoxicity and Immunosuppression of Combustible Tobacco Product Preparations
09:25

Methods to Evaluate Cytotoxicity and Immunosuppression of Combustible Tobacco Product Preparations

Published on: January 10, 2015

11.4K

[Smoking and tuberculosis].

Jean Perriot1, Gérard Peiffer2, Michel Underner3

  • 1Pneumologue, addictologue, centre de lutte antituberculeuse du Puy-de-Dôme (CLAT 63), dispensaire Émile-Roux, Clermont-Ferrand, France.

La Revue Du Praticien
|June 4, 2024
PubMed
Summary
This summary is machine-generated.

Smoking significantly worsens tuberculosis outcomes, increasing infection risk and disease severity. Quitting smoking improves treatment adherence and cure rates for tuberculosis patients.

Keywords:
Tobacco SmokingTuberculosis

More Related Videos

Cigarette Smoke Exposure in Mice using a Whole-Body Inhalation System
06:07

Cigarette Smoke Exposure in Mice using a Whole-Body Inhalation System

Published on: October 22, 2020

6.5K
An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
09:34

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis

Published on: August 16, 2021

1.8K

Related Experiment Videos

Last Updated: Jun 24, 2025

Methods to Evaluate Cytotoxicity and Immunosuppression of Combustible Tobacco Product Preparations
09:25

Methods to Evaluate Cytotoxicity and Immunosuppression of Combustible Tobacco Product Preparations

Published on: January 10, 2015

11.4K
Cigarette Smoke Exposure in Mice using a Whole-Body Inhalation System
06:07

Cigarette Smoke Exposure in Mice using a Whole-Body Inhalation System

Published on: October 22, 2020

6.5K
An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
09:34

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis

Published on: August 16, 2021

1.8K

Area of Science:

  • Public Health
  • Infectious Diseases
  • Respiratory Medicine

Background:

  • Tuberculosis (TB) remains a leading cause of global mortality, with 9 million incident cases and 1.6 million deaths annually.
  • Smoking is a major risk factor, increasing susceptibility to Mycobacterium tuberculosis infection and exacerbating TB disease severity, including mortality and recurrence.

Purpose of the Study:

  • To highlight the detrimental impact of smoking on tuberculosis.
  • To emphasize the benefits of smoking cessation in managing tuberculosis.
  • To advocate for healthcare professional involvement in aiding smoking cessation among tuberculosis patients.

Main Methods:

  • Literature review and synthesis of existing research on the interplay between smoking and tuberculosis.
  • Analysis of epidemiological data on tuberculosis incidence, mortality, and risk factors.
  • Evaluation of the impact of smoking cessation interventions on tuberculosis treatment outcomes.

Main Results:

  • Smoking elevates the risk of acquiring tuberculosis infection.
  • Smokers with tuberculosis experience more severe disease, higher mortality rates, and increased risk of recurrence.
  • Smoking cessation demonstrably improves the prognosis of tuberculosis, enhancing treatment adherence and leading to definitive cures.

Conclusions:

  • Smoking cessation is a critical intervention for improving tuberculosis patient outcomes.
  • Integrating smoking cessation support into routine tuberculosis care is essential for effective disease management and public health.
  • Healthcare professionals play a vital role in motivating and assisting patients with tuberculosis to quit smoking.